Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Young, R. Hopkins, B. Hay, C. Whittington, G. Gamble (Auckland, New Zealand). Late Breaking Abstract: FAM13A gene confers reduced risk of COPD and lung cancer in current and former smokers. Eur Respir J 2010; 36: Suppl. 54, 3547

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - The effects of smoking cessation and FAM13A gene susceptibility on lung function decline: A 16-year follow-up study among male smokers Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings Year: 2018 Association of the PDCD5 locus with lung cancer risk and prognosis in smokers Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007 Late Breaking Abstract: Gene-based risk test for lung cancer risk motivates smoking cessation in randomly selected smokers Source: Annual Congress 2010 - Smoking related disorders Year: 2010 Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients Source: International Congress 2016 – Studies in airway cell biology Year: 2016 COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer? Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Lymphopenia is linked to an increased incidence of cancer in smokers without COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Poor self regulation correlates with the incidence of lung cancer in smokers Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis Year: 2017 Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Source: Eur Respir J 2008; 32: 1158-1164 Year: 2008 COPD and lung cancer incidence in never smokers Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019 Novel genes associated with the level of FEV1 in never-smokers in the context of occupational exposure Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis Source: International Congress 2018 – Biomarkers of COPD Year: 2018 TERT expression in lung cancer associated with IPF: a case-control study Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Reduced FEV3/FVC identifies smokers at risk of developing COPD in the SPIROMICS cohort Source: International Congress 2018 – Respiratory muscles and lung function: from healthy subjects to patients Year: 2018 Identifying the at risk smokers: who goes on to get COPD? Source: Eur Respir J, 54 (4) 1901613; 10.1183/13993003.01613-2019 Year: 2019 What is real prevalence of COPD in patients with lung cancer? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 COPD in patients with lung cancer and smoking Source: Eur Respir J 2005; 26: Suppl. 49, 519s Year: 2005 Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Late Breaking Abstract: Improved prediction of COPD in patients at risk by lung function pre-screening in primary care Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010 Late Breaking Abstract - Endobronchial gene-expression clustering in COPD identifies a subgroup with higher level of lymphocytes and accelerated lung function decline Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018